Metformin and pioglitazone combination therapy ameliorate polycystic ovary syndrome through AMPK/PI3K/JNK pathway.

about

Metformin and pioglitazone combination therapy ameliorate polycystic ovary syndrome through AMPK/PI3K/JNK pathway.

Item

http://www.wikidata.org/entity/Q49478090

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Metformin and pioglitazone com ...... through AMPK/PI3K/JNK pathway.

@en

Metformin and pioglitazone com ...... through AMPK/PI3K/JNK pathway.

@nl

type

Item

label

Metformin and pioglitazone com ...... through AMPK/PI3K/JNK pathway.

@en

Metformin and pioglitazone com ...... through AMPK/PI3K/JNK pathway.

@nl

prefLabel

Metformin and pioglitazone com ...... through AMPK/PI3K/JNK pathway.

@en

Metformin and pioglitazone com ...... through AMPK/PI3K/JNK pathway.

@nl

P1476

Metformin and pioglitazone com ...... through AMPK/PI3K/JNK pathway.

@en

P2093

Dan Zhang

http://www.w3.org/2001/XMLSchema#string

Pengfen Li

http://www.w3.org/2001/XMLSchema#string

Yingpu Sun

http://www.w3.org/2001/XMLSchema#string

Yuanyuan Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility

Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways.

The prevalence and features of the polycystic ovary syndrome in an unselected population.

Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes.

The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study.

Phenotype and metabolic disorders in polycystic ovary syndrome.

Effects of jnk inhibitor on inflammation and fibrosis in the ovary tissue of a rat model of polycystic ovary syndrome

P304

2120-2127

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2017.5650

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29434814

http://www.w3.org/2001/XMLSchema#string

P921

metformin

polycystic ovary syndrome

P932

5776642

http://www.w3.org/2001/XMLSchema#string